Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Succinyl phosphonate (trisodium salt)

Succinyl phosphonate trisodium salt is an α-ketoglutarate dehydrogenase (KGDHC) inhibitor, effective inhibits (KGDHC) in muscle, bacterial, brain, and cultured human fibroblasts[1][4]. Succinyl phosphonate trisodium salt is an 2-oxoglutarate dehydrogenase (OGDH) inhibitor, impairs viability of cancer cells in a cell-specific metabolism-dependent manner[2]. Succinyl phosphonate trisodium salt inhibits the glutamate-induced ROS production in glutamate-stimulated hippocampal neurons in situ[3].

Product Specifications

CAS Number

[864167-45-3]

UNSPSC

12352211

Target

Endogenous Metabolite; Reactive Oxygen Species (ROS)

Type

Reference compound

Related Pathways

Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

Applications

Neuroscience-Neurodegeneration

Field of Research

Cancer; Metabolic Disease; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/succinyl-phosphonate-trisodium-salt.html

Purity

98.0

Solubility

H2O : 50 mg/mL (ultrasonic)

Smiles

O=C(O[Na])CCC(P(O[Na])(O[Na])=O)=O

Molecular Formula

C4H4Na3O6P

Molecular Weight

248.01

References & Citations

[1]Biryukov AI, et al. Succinyl phosphonate inhibits alpha-ketoglutarate oxidative decarboxylation, catalyzed by alpha-ketoglutarate dehydrogenase complexes from E. coli and pigeon breast muscle. FEBS Lett. 1996 Mar 11;382 (1-2) :167-70.|[2]Bunik VI, et al. Inhibition of mitochondrial 2-oxoglutarate dehydrogenase impairs viability of cancer cells in a cell-specific metabolism-dependent manner. Oncotarget. 2016 May 3;7 (18) :26400-21.|[3]Zündorf G, et al. alpha-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ. Neuroscience. 2009 Jan 23;158 (2) :610-6.|[4]Bunik VI, et al. Phosphonate analogues of alpha-ketoglutarate inhibit the activity of the alpha-ketoglutarate dehydrogenase complex isolated from brain and in cultured cells. Biochemistry. 2005 Aug 9;44 (31) :10552-61.|[5]Artiukhov AV, et al. Increasing Inhibition of the Rat Brain 2-Oxoglutarate Dehydrogenase Decreases Glutathione Redox State, Elevating Anxiety and Perturbing Stress Adaptation. Pharmaceuticals (Basel) . 2022 Jan 31;15 (2) :182.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

BioRxiv. 2024 Jan 15.|Clin Rheumatol. 2025 Nov 20.|Research Square Preprint. 2022.|Research Square Print. 2022 May.|ACS Chem Biol. 2020 Aug 21;15 (8) :2041-2047.|Cancer Res. 2019 Jul 1;79 (13) :3281-3293. |Cell Death Dis. 2021 Oct 25;12 (11) :999.|Exp Cell Res. 2019 Sep 15;382 (2) :111483.|Free Radic Biol Med. 2016 Jul:96:22-33.|Plant Signal Behav. 2019;14 (7) :1604015.|Planta. 2018 Oct;248 (4) :963-979.|Redox Biol. 2023 Jun:62:102669.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Human GFER (N-6His)
PEH0727-01 10 µg

Recombinant Human GFER (N-6His)

Ask
View Details
Recombinant Human GFER (N-6His)
PEH0727-02 50 µg

Recombinant Human GFER (N-6His)

Ask
View Details
Recombinant Human GFER (N-6His)
PEH0727-03 500 µg

Recombinant Human GFER (N-6His)

Ask
View Details
Rabbit Polyclonal OTUD4 Antibody [Janelia Fluor 549]
NBP1-77003JF549 0.1 mL

Rabbit Polyclonal OTUD4 Antibody [Janelia Fluor 549]

Ask
View Details
FMD (Foot and Mouth Disease, FMDV) (MaxLight 405) discontinued
F4610-02-ML405 100 µL

FMD (Foot and Mouth Disease, FMDV) (MaxLight 405) discontinued

Ask
View Details
A1ATR Polyclonal Antibody
JOT-AP13967-01 50ul

A1ATR Polyclonal Antibody

Ask
View Details